Yan Tan

Title: Yan Tan: Innovator in SARS-CoV-2 Research

Introduction

Yan Tan is a notable inventor based in Saugus, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and binding agents related to SARS-CoV-2. With a total of 2 patents, his work is crucial in the ongoing fight against COVID-19.

Latest Patents

Yan Tan's latest patents focus on the production of recombinant SARS-CoV-2 spike protein in a pre-fusion state. The first patent discloses methods for producing this protein using furin knock out or knockdown mammalian cells, such as HEK293 and CHO cells. These proteins are essential for generating antibodies and related binding agents that can be utilized in SARS-CoV-2 detection assays and for diagnosing active or prior infections. The second patent similarly addresses the production of binding agents to the pre-fusion state SARS-CoV-2 spike protein, emphasizing their potential use in prophylaxis and therapeutic applications against coronaviruses related to SARS-CoV-2.

Career Highlights

Throughout his career, Yan Tan has worked with various organizations, including Abclonal Science, Inc. His expertise in recombinant protein production and antibody development has positioned him as a key player in the biotechnology sector.

Collaborations

Yan Tan has collaborated with Yang Xiang, a talented woman in the field, to further advance their research and innovations.

Conclusion

Yan Tan's contributions to the field of biotechnology, particularly in the context of SARS-CoV-2, highlight his innovative spirit and dedication to improving public health. His patents and collaborative efforts are paving the way for advancements in detection and treatment methods for COVID-19 and related viruses.